LivaNova (NASDAQ:LIVN) Shares Gap Down – Here’s What Happened

LivaNova PLC (NASDAQ:LIVN) shares gapped down before the market opened on Wednesday . The stock had previously closed at $85.32, but opened at $79.88. LivaNova shares last traded at $78.58, with a volume of 170,812 shares trading hands.

Analysts Set New Price Targets

Several brokerages recently weighed in on LIVN. Zacks Research raised shares of LivaNova from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 21st. Needham & Company LLC raised their price target on LivaNova from $81.00 to $93.00 and gave the company a “buy” rating in a report on Wednesday. KeyCorp upped their price objective on LivaNova from $83.00 to $92.00 and gave the stock an “overweight” rating in a research note on Monday, June 22nd. Stifel Nicolaus set a $85.00 target price on LivaNova in a research report on Wednesday. Finally, Freedom Capital raised LivaNova to a “hold” rating in a research note on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $83.50.

LivaNova Stock Performance

The business’s fifty day moving average is $79.60 and its two-hundred day moving average is $70.71. The stock has a market capitalization of $4.17 billion, a PE ratio of 22.58 and a beta of 0.86. The company has a quick ratio of 1.11, a current ratio of 1.45 and a debt-to-equity ratio of 0.22.

LivaNova (NASDAQ:LIVN) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.17. LivaNova had a net margin of 12.82% and a return on equity of 16.36%. The company had revenue of $390.59 million for the quarter, compared to the consensus estimate of $380.50 million. During the same quarter in the prior year, the firm earned $1.05 earnings per share. LivaNova’s revenue was up 10.8% on a year-over-year basis. LivaNova has set its FY 2026 guidance at 4.300-4.400 EPS. As a group, research analysts anticipate that LivaNova PLC will post 3.73 EPS for the current fiscal year.

Insider Buying and Selling at LivaNova

In related news, Director Francesco Bianchi sold 1,800 shares of LivaNova stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $75.75, for a total value of $136,350.00. Following the completion of the transaction, the director owned 7,228 shares in the company, valued at approximately $547,521. This trade represents a 19.94% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.35% of the stock is currently owned by company insiders.

Institutional Trading of LivaNova

A number of institutional investors have recently bought and sold shares of LIVN. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in LivaNova by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,497 shares of the company’s stock valued at $1,394,000 after acquiring an additional 1,360 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of LivaNova by 4.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 814,974 shares of the company’s stock worth $32,012,000 after acquiring an additional 36,094 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of LivaNova by 10.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 168,863 shares of the company’s stock worth $6,633,000 after acquiring an additional 15,405 shares during the last quarter. Intech Investment Management LLC boosted its stake in shares of LivaNova by 19.6% during the 1st quarter. Intech Investment Management LLC now owns 43,879 shares of the company’s stock worth $1,724,000 after purchasing an additional 7,195 shares during the period. Finally, Strs Ohio purchased a new position in shares of LivaNova during the 1st quarter worth about $130,000. 97.64% of the stock is currently owned by institutional investors.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.